SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-136622
Filing Date
2021-11-10
Accepted
2021-11-10 07:40:16
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132321d1_8k.htm   iXBRL 8-K 28296
2 EXHIBIT 99.1 tm2132321d1_ex99-1.htm EX-99.1 78164
6 GRAPHIC tm2132321d1_ex99-1img001.jpg GRAPHIC 4914
  Complete submission text file 0001104659-21-136622.txt   295508

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ipsc-20211110.xsd EX-101.SCH 3028
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipsc-20211110_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipsc-20211110_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2132321d1_8k_htm.xml XML 3604
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40498 | Film No.: 211394437
SIC: 2836 Biological Products, (No Diagnostic Substances)